ImmuneBiotech is a team driven by innovative spirit, calculated risk taking, and sense of communal responsibility. Its vision is to achieve international recognition for excellence of research, and to be at the forefront in generating and using new knowledge for creating cost-efficient advancements that have a true impact on health.
ImmuneBiotech AB and ImmuneBiotech RTCE were both founded by Dr. Shahram Lavasani who holds a PhD degree from Lund University in medical inflammation research from Lund University. He has been teaching immunology for 10 years and initiated innovative and exclusive immunotherapies for Multiple Sclerosis. His recent scientific achievement within the field of probiotics has received a major national and international media attraction. He has been invited to international meetings and been interviewed by different Swedish and international newspapers and TV programs.
Mehrnaz Nouri is the co-founder of the companies who is an expert in the field of biotechnology and probiotic research. She has patented several strains of lactobacilli and developed a novel vaccination against Salmonella infection. She holds a position as a senior scientist within the company.
Associate professor Anders Bredberg has joined the team as an experienced clinician and a top researcher within the fields of microbiology, autoimmunty and cancer.
Peter Johnsson has a BSc in Economics and Business Administration. He has twenty years of experience from working as a consultant, specializing in startup companies. He has been the Chairman of the Board of two companies, Trimera and OBMgruppen, for several years and is presently a member of the Board in Gear Up AB. He has been running his own Management Consulting Business since 2001.
Karin Larsson has a Ph.D. in Biotechnology, Lund University and a Diploma in Marketing management, EFL, School of Economics and Management, Lund University. She has twenty years experience in the Pharma and Life-Science industry and more than ten years experience in Business Development, working in both small and large organization including Novo Nordisk A/S, (now Novozymes), Bioglan AB and Alligator Bioscience AB. Karin is a co-founder and co-owner of the consultancy company Vetenskaps Fabriken AB.